Literature DB >> 7727686

Molecular studies on interleukin-1 alpha.

Y Furutani1.   

Abstract

When rabbit alveolar macrophages were treated with phorbol-12-myristate-13-acetate (PMA) and lipopolysaccharide (LPS), the synthesis of interleukin-1 (IL-1), as well as tumor necrosis factor (TNF), was greatly increased. These inducible cytokines were subjected to cloning by the differential colony hybridization method and the subsequent mRNA hybridization-translation assay. Cloned rabbit IL-1 cDNA was disclosed to encode the sequence of the counterpart of the mouse IL-1 alpha. This cDNA was used as a hybridization probe to screen a human cDNA library which was constructed from induced HL-60 cells, a human promyelocytic leukemia cell line. Isolated human IL-1 alpha cDNA was shown to direct the synthesis of a polypeptide with IL-1 activity in E. coli expression system. The chromosomal gene for human IL-1 alpha was isolated and characterized to elucidate the structural organization of this gene. To identify the region that is essential for regulating IL-1 alpha gene expression, various CAT (chloramphenicol acetyltransferase) fusion plasmids were constructed and analysed for their ability to direct CAT synthesis in a transient expression system. The unpublished results obtained in the early stages of these experiments are also presented and discussed in this review.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7727686

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  2 in total

1.  Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways.

Authors:  L Rabehi; T Irinopoulou; B Cholley; N Haeffner-Cavaillon; M P Carreno
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Differentially methylated alleles in a distinct region of the human interleukin-1alpha promoter are associated with allele-specific expression of IL-1alpha in CD4+ T cells.

Authors:  Johanna G I van Rietschoten; Kitty F Verzijlbergen; Sonja I Gringhuis; Tineke C T M van der Pouw Kraan; Jean-Pierre Bayley; Eddy A Wierenga; Peter A Jones; Jan M Kooter; Cor L Verweij
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.